Abbott Laboratories Cuts Cost of AIDS Drug for Government Programs

Chicago Tribune -- Abbott Laboratories this week reduced the price of its popular AIDS drug Kaletra for some customers.

The move, disclosed Friday during the company's annual shareholders meeting, comes amid reductions in government spending on programs for low-income Americans with HIV.

Cash-strapped states such as Illinois have curtailed eligibility for people enrolled in AIDS drug assistance programs, which also receive federal funds. Meanwhile, there has been an influx of applicants for AIDS drug assistance programs as people have lost jobs and their ability to pay for HIV prescriptions.

Back to news